How confident are you at managing Drug-drug interactions involving COVID-19 treatment and common concomitant medications?
Do you think that focusing on common DDI’s in a proactive fashion using reimbursable pharmacy services is more cost effective than addressing DDI’s when a patient comes to you with a positive test?
How confident are you in dispensing COVID-19 treatment in a patient who has not had a renal function test (eGFR or SCr) in the past year?
Do you see opportunities to improve your workflow after completing this module?